App-based care after heart ablation
Part of Heart & circulation clinical trials.
This study tests whether a smartphone app can help people recover after a new type of heart ablation called pulse field ablation for atrial fibrillation. It aims to see if the app improves follow-up care and quality of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have atrial fibrillation and are getting pulse field ablation for the first time.
- You are 18 years or older.
- You are willing to use a smartphone app for your care.
- You do not have a blood clot in your heart or a recent stroke or heart attack.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new type of energy (pulsed field) to treat abnormal heart rhythms. It may be less damaging to nearby tissues than traditional ablation.
This trial tests a new way to deliver energy (FARAPULSE PFA system) to treat atrial fibrillation (AF), a type of irregular heartbeat. It aims to see if these new waveforms can safely and effectively stop AF symptoms and improve quality of life.
This registry is collecting information to see how well the Farapulse PFA system works and how safe it is for treating atrial fibrillation (AF), a common heart rhythm problem. If you are scheduled to have an ablation for AF with this system, this study will follow your progress.
This trial tests a new tool called FARAFLEX that uses pulsed electrical energy to treat atrial fibrillation (an irregular heart rhythm). The goal is to see if this method can safely stop AF symptoms in people whose medications haven't worked.
This trial tests a newer type of ablation (pulsed field ablation) for people with persistent atrial fibrillation who have already had one ablation. The goal is to see if it can fix the heart rhythm problem again.
This trial tests a new type of ablation called PFA for people with persistent atrial fibrillation. It aims to see if targeting heart tissue changes can improve outcomes.
Hear when a new Atrial Fibrillation Patients Treated With the FARAPULSE™ PFA System trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.